Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
ST

Stephen Thom — 44 Patents

Astrazeneca Ab: 26 patents #7 of 1,971Top 1%
ILInflazome Limited: 12 patents #5 of 20Top 25%
DCDainippon Sumitomo Pharma Co.: 7 patents #3 of 256Top 2%
ALAstrazeneca Uk Limited: 3 patents #28 of 159Top 20%
ALAstra Pharmaceuticals Limited.: 2 patents #10 of 36Top 30%
SCSumitomo Dainippon Pharma Co.: 1 patents #104 of 206Top 55%
Nottingham, GB: #2 of 843 inventorsTop 1%
Overall (All Time): #66,838 of 4,157,543Top 2%
44 Patents All Time
Stephen Thom has been granted 44 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 1999 and the most recent in February 2025. Stephen Thom ranks #66,838 of 4,157,543 US inventors in our database (top 1.6%). Patent records list Stephen Thom in Nottingham, GB.

Issued Patents All Time

Showing 1–25 of 44 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12221434 Sulfonamide carboxamide compounds Matthew Cooper, David Miller, Angus Murray MacLeod, Jonathan Shannon, Jokin Carrillo Arregui 2025-02-11
12012392 Sulfonamide carboxamide compounds Matthew Cooper, David Miller, Angus Murray MacLeod, Stephen St-Gallay, Jonathan Shannon +1 more 2024-06-18
11981667 Sulfonamide carboxamide compounds Matthew Cooper, David Miller, Angus Murray MacLeod, Jimmy Van Wiltenburg, Stephen St-Gallay +1 more 2024-05-14
11926600 Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors Matthew Cooper, David Miller, Angus Murray MacLeod, Stephen St-Gallay, Jonathan Shannon 2024-03-12
11773058 Sulfonamide carboxamide compounds David Miller, Angus Murray MacLeod, Jimmy Van Wiltenburg, Stephen St-Gallay, Jonathan Shannon 2023-10-03
11724988 Processes Daniel Schwizer, Sascha Breeger, Thomas ALANINE 2023-08-15
11623922 Compounds David Miller, Stephen St-Gallay, Jonathan Shannon, Paul D. Leeson 2023-04-11
11613542 Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors Matthew Cooper, David Miller, Angus Murray MacLeod, Stephen St-Gallay, Jonathan Shannon +4 more 2023-03-28
11542255 Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors Matthew Cooper, David Miller, Angus Murray MacLeod, Stephen St-Gallay, Jonathan Shannon +3 more 2023-01-03
11518739 Sulfonamide carboxamide compounds David Miller, Angus Murray MacLeod, Jimmy Van Wiltenburg, Stephen St-Gallay, Jonathan Shannon 2022-12-06
11465992 Sulfonamide carboxamide compounds Matthew Cooper, David Miller, Angus Murray MacLeod, Jimmy Van Wiltenburg, Stephen St-Gallay +1 more 2022-10-11
11370776 Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors Matthew Cooper, David Miller, Angus Murray MacLeod, Jimmy Van Wiltenburg, Stephen St-Gallay +1 more 2022-06-28
9533978 Pyrimidine derivatives and their use in the treatment of cancer and further diseases Nicholas James Bennett, Thomas McInally 2017-01-03
8895570 Purine derivatives Phillip G. Abbott, Roger Bonnert, Thomas McInally, Hiroki Wada, Satoshi Onuma 2014-11-25 $25,833,000
8765939 Pyrimidline derivatives having immune modulating properties that act via TLR7 for the treatment of viral or allergic diseases and cancers Nicholas James Bennett, Thomas McInally, Tobias Mochel, Anna-Karin Tiden 2014-07-01 $74,173,000
8524715 Phenoxyacetic acid derivatives useful for treating respiratory diseases Roger Bonnert, Lilian Alcaraz, Rukhsana Tasneem Mohammed, Anthony Ronald Cook, Timothy Jon Luker 2013-09-03 $19,426,000
8436178 Imidazoquinolines with immuno-modulating properties Roger Bonnert, Thomas McInally, Hiroki Wada 2013-05-07 $7,216,000
8415394 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease Timothy Jon Luker, Rukhsana Tanseem Mohammed, Mark Dickinson 2013-04-09 $7,902,000
8394986 Phenoxiacetic acid derivatives Roger Bonnert, Anil Patel 2013-03-12 $7,268,000
8349897 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease Timothy Jon Luker, Rukhsana Tanseem Mohammed, Mark Dickinson 2013-01-08 $21,979,000
8268990 Compounds Nicholas James Bennett, Thomas McInally 2012-09-18 $6,569,000
8158820 Compounds Roger Bonnert, Stephen Brough, Andrew Davies, Timothy Jon Luker, Thomas McInally +4 more 2012-04-17 $6,204,000
8148572 Compounds Timothy Jon Luker, Rukhsana Tasneem Mohammed, Anil Patel 2012-04-03 $2,984,000
8138172 8-oxoadenine derivatives acting as modulators of TLR7 Anthony Ronald Cook, Tom McInally, Hiroki Wada 2012-03-20 $9,557,000
8067413 9-substituted-8-oxo-adenine compounds as toll-like receptor (TLR7 ) modulators Roger Bonnert, Thomas McInally 2011-11-29 $4,580,000